Cargando...
Cabazitaxel (Jevtana): A Novel Agent for Metastatic Castration-Resistant Prostate Cancer
OBJECTIVE: This article presents current clinical evidence supporting the use of cabazitaxel (Jevtana) in men with metastatic castration-resistant prostate cancer (mCRPC). DATA SOURCES: We conducted a literature search using abstracts from MEDLINE and PubMed (from January 1966 to December 2011) and...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MediMedia USA, Inc.
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3474423/ https://ncbi.nlm.nih.gov/pubmed/23091336 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|